Toshiba boosts Infinix-i image quality

Article

Other headlinesGMI builds clinical war ches

Toshiba boosts Infinix image quality
Toshiba America Medical Systems unveiled Sept 21 a low-contrast capability for Infinix-i systems that feature mid- and large-size flat panel detectors. The new capability was a feature of its exhibit at the Transcatheter Cardiovascular Therapeutics  meeting in San Francisco. The Low-Contrast Imaging (LCI) technology enables better visualization of soft tissue in the angio suite, according to the company, delivering CT-like images of the liver, brain, and cerebral ventricles. LCI may be used to improve diagnosis, as well as to confirm appropriate endpoints during interventional procedures, such as aortic stent-grafting, the company said. The Infinix-i line features a five-axis C-arm that covers patients head-to-toe and fingertip-to-fingertip. 

GMI builds clinical war chest
Gamma Medica-Ideas has raised $24 million to support efforts to grow its presence in the clinical marketplace with digital SPECT, PET, and CT products. Psilos Group, a healthcare venture capital firm, and Capital Resource Partners, a provider of hybrid growth financing, contributed $14 million in equity capital. Capital Resource Partners also provided $5 million in mezzanine debt. The technology lending group at Bridge Bank rounded out the financing with a $5 million revolving line of credit. Historically, GMI has served the pre-clinical imaging market, where the need for increased productivity is driving demand for medical research and drug discovery applications. Its small animal imaging products are distributed in Japan by SII NanoTechnology and elsewhere by GE Healthcare. With this financing, GMI plans to leverage its digital imaging technology platform into clinical imaging markets, where the company will promote its products as the means to improved diagnosis at lower costs. GMI’s initial product, LumaGEM, is focused on improving the diagnosis of cancers in women with dense breast tissue.
 

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.